Investors

Marinus is committed to maximizing shareholder value by developing and commercializing ganaxolone for treatment of drug-resistant seizures in both the hospital and home settings.

NASDAQ: MRNS
$ 1.17 0.00 (0.00%)
Day High: 1.20
Day Low:  1.14
Volume:    141,647
4:00 PM ET
May 26, 2017

Delayed ~20 min., by eSignal.